Weekly Fungal Diagnostics Update: April 7-13

Posted on by

Coverage: key papers identified from this week’s Search A and Search B results, focusing on fungal diagnostics, invasive mould infection, and clinically relevant laboratory advances.

Key points this week

  • Two strong review papers provide an excellent overview of where invasive mould diagnostics currently stand, especially for Aspergillus and Mucorales.
  • Galactomannan, fungal PCR, and combined diagnostic strategies remain central, but all have important limitations depending on patient group and sample type.
  • A notable original research paper shows that artificial intelligence-based microscopic morphology recognition may help identify Aspergillus rapidly to section and species level.
  • A new study comparing a rapid phenotypic identification strategy for Candida albicans against PCR highlights continued interest in practical, lower-complexity laboratory methods.
  • There is growing interest in non-invasive or emerging biomarkers, including urinary glycans, siderophores, and other molecular approaches, but these are not yet routine in most centres.
  • One important mechanistic paper suggests that azole persistence may precede full azole resistance in Aspergillus fumigatus, raising questions about how well current diagnostics detect early antifungal tolerance states.

Contents

This week’s main diagnostic themes

This week’s results were dominated by two very useful review articles on invasive mould infection, alongside a smaller number of original papers with more direct diagnostic relevance. Taken together, the papers reinforce several familiar themes.

  • No single test is enough. Diagnosis of invasive mould disease still depends on combining clinical context, imaging, biomarkers, molecular tests, and conventional microbiology.
  • Galactomannan remains important, particularly in invasive aspergillosis, but interpretation depends on the host, sample type, and prior antifungal exposure.
  • PCR is increasingly established as a complementary diagnostic tool for Aspergillus and Mucorales, and may allow earlier detection than culture in some settings.
  • New technologies are moving diagnostics forward, including artificial intelligence-assisted microscopy, non-invasive biomarker discovery, and broader molecular approaches.
  • Routine diagnostics still have blind spots, especially around antifungal tolerance, resistance evolution, and the early phases of infection.

1) Laboratory innovations to diagnose invasive mould infections – what is relevant, what is not?

Vanbiervliet Y, Aerts R, Maessen L, Wauters J, Maertens J, Lagrou K.
Clinical Microbiology and Infection. 2026 May;32(5):715-728.
PMID: 41173342

This is one of the most useful papers in this week’s set. It reviews current and emerging laboratory tools for diagnosing invasive mould infection, with particular relevance to invasive aspergillosis and mucormycosis.

Main messages

  • Culture still matters, but it is often too slow and insensitive to be relied on alone.
  • Targeted PCR assays for Aspergillus and Mucorales are increasingly valuable and may allow earlier detection than conventional methods.
  • Molecular methods may also help with rapid detection of resistance-associated markers, which is especially relevant in Aspergillus fumigatus.
  • Emerging targets such as urinary glycans and siderophores are promising because they raise the possibility of more non-invasive diagnostics.

Why this matters

The paper supports a direction of travel already visible in specialist mycology: diagnosis is moving away from a single “gold standard” test and toward a layered approach combining biomarker, molecular, microbiological, and radiological evidence.

It also gives a useful reality check. Some laboratory innovations are promising, but not all are ready for routine use. That distinction is important, especially for clinicians and laboratories trying to decide which new approaches are truly likely to improve care.

2) Invasive mould infection in children – advances made or obstacles remaining?

Yeoh DK, Butters C, Clark JE, Slavin MA, McMullan BJ, Haeusler GM, Blyth CC.
Clinical Microbiology and Infection. 2026 May;32(5):740-748.
PMID: 41317867

This review focuses on paediatric invasive mould infection, a group in whom diagnosis is often especially difficult. Although the paper is children-focused, many of its messages are broadly applicable.

Main messages

  • Imaging is important but not specific. It may suggest invasive fungal disease, but often cannot reliably distinguish between different mould infections.
  • Non-culture biomarkers, especially galactomannan, still play a significant role in paediatric invasive aspergillosis.
  • However, biomarker performance is not uniform. Sensitivity and interpretation can vary depending on:
    • host factors
    • sample type
    • underlying disease
    • prior or ongoing antifungal therapy
  • PCR and combined testing strategies are increasingly relevant, particularly where there is a need to improve diagnostic confidence.

Why this matters

This paper reinforces a key practical point: fungal diagnostics are always affected by context. A test that performs well in one group may be less helpful in another. That is particularly relevant in paediatrics, but it also applies more widely in transplant, haematology, and intensive care settings.

3) Identification of Aspergillus at section and species levels by artificial intelligence-based microscopic morphology image recognition

Tan M, Guo Z, Wang Y, Xu X, Cao W, Liu Z, Jiang C.
Journal of Clinical Microbiology. 2026 Apr 8;64(4):e00012-26.
PMID: 41757926

This is one of the most interesting original research papers in this week’s set. The study describes an artificial intelligence-based image recognition system for identifying Aspergillus by microscopic morphology.

Main messages

  • The system appears able to identify Aspergillus to section and species level from morphology images.
  • The aim is to improve the speed and accuracy of fungal identification in clinical microbiology laboratories.
  • This is particularly relevant because rapid identification of Aspergillus species can influence:
    • diagnostic confidence
    • risk assessment
    • interpretation of susceptibility and resistance patterns

Why this matters

Traditional microscopic morphology remains highly valuable, but it requires expertise and can be subjective. Tools that standardise or accelerate interpretation could be especially helpful in laboratories with variable mycology experience. This is not a replacement for specialist input, but it may become a useful adjunct.

4) A combined rapid phenotypic strategy for the identification of Candida albicans: performance evaluation against PCR

Jabri B, Faouzi S, Bouzit A, Chtibi H, Assimi S, Iken M.
Diagnostic Microbiology and Infectious Disease. 2026 Jul;115(3):117388.
PMID: 41880733

This study evaluates a rapid phenotypic identification strategy for Candida albicans against PCR.

Main messages

  • The work highlights continued interest in rapid, practical laboratory methods that can be used in routine settings.
  • It is particularly relevant because Candida albicans must sometimes be distinguished from closely related yeasts such as Candida dubliniensis.
  • The study helps illustrate the ongoing balance between:
    • higher-complexity molecular methods
    • faster and cheaper phenotypic workflows

Why this matters

Not every laboratory can adopt every molecular method immediately. Practical phenotypic strategies that perform well against PCR comparators remain highly relevant, especially where cost, staffing, or turnaround pressures shape diagnostic pathways.

5) Candida auris colonization and bloodstream infection in selected intensive care units of Dhaka city, Bangladesh

Chowdhury F, Mah-E-Muneer S, Khan S, Lyman M, Mamun GMS, Lockhart SR, Habib ZH, Rahman A, Hossain K, Hassan Z, Prema S, Islam MA, Ahmed D, Sen D, Rahman M, Jordan A.
Microbiology Spectrum. 2026 Apr 7;14(4):e03169-25.
PMID: 41711477

This is more of a screening, surveillance, and infection-control paper than a pure diagnostics methods paper, but it is still relevant to fungal diagnostics in practice.

Main messages

  • The authors looked at both colonisation screening and bloodstream infection in intensive care settings.
  • Identification methods included routine laboratory systems and susceptibility testing.
  • The paper underlines the continuing challenge of Candida auris as both a diagnostic and infection prevention problem.

Why this matters

Candida auris remains important because it combines difficult identification, potential multidrug resistance, and significant outbreak potential. Even when a paper is more epidemiological than methodological, it can still be highly relevant to diagnostic services.

6) Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus

Delbaje E, Pontes L, Savoldi M, Sedik S, Dichtl K, Hoenigl M, Lass-Flörl C, Silva Pereira C, Schreiber AZ, Rokas A, Lu L, Barbosa JCJ, Fill T, Dos Reis TF, Goldman GH.
Microbiology Spectrum. 2026 Apr 7;14(4):e04021-25.
PMID: 41837673

This paper is not a direct diagnostics study, but it may prove quite important conceptually. It suggests that azole persistence can arise before full, genetically established azole resistance develops in Aspergillus fumigatus.

Main messages

  • There may be an intermediate state between full susceptibility and established resistance.
  • This state is linked to persistence and stress tolerance.
  • Standard susceptibility testing may not fully capture this biology.

Why this matters

This raises an important longer-term diagnostics question: are current tests good enough at identifying patients or isolates at risk of treatment failure before classical resistance becomes obvious? The paper does not answer that fully, but it points to a potentially important blind spot in current antifungal diagnostics.

7) Other noteworthy developments

Invasive aspergillosis in lung and heart transplant recipients

Morrissey CO.
JHLT Open. 2026 Jan 20;12:100494.
PMID: 41736996

This review is broader than diagnostics alone, but transplant recipients remain one of the most important high-risk groups for invasive aspergillosis. The paper is useful background reading because diagnosis in these patients is particularly time-sensitive and complex.

A screening pipeline for human proteins interacting with the Aspergillus fumigatus melanin virulence determinant

Danesh M, Osmanoglu Ö, Gupta SK, Heineking I, Brakhage AA, Kniemeyer O, Dandekar T.
Computers in Biology and Medicine. 2026 May 1;207:111624.
PMID: 41886923

This is an early-stage mechanistic paper rather than a current diagnostics paper, but it may eventually contribute to work on host–pathogen interaction markers or new biomarker targets.

Overall interpretation

This week’s update was shaped more by high-quality reviews than by a large number of major original diagnostics trials, but there were still several useful developments.

The broad message is consistent with where the field has been heading for some time:

  • diagnosis of invasive fungal disease remains multimodal
  • PCR and biomarker testing are increasingly established, not merely experimental
  • newer non-invasive and technology-enabled approaches are beginning to emerge, but are not yet routine
  • important gaps remain, especially around resistance evolution, tolerance states, and performance across different patient populations

For aspergillosis in particular, the most useful take-home points this week are:

  • galactomannan remains central, but must always be interpreted in context
  • Aspergillus PCR is becoming increasingly important as part of combined diagnostic pathways
  • artificial intelligence-assisted microscopy may become a practical laboratory aid in the future
  • diagnostics may eventually need to do more than detect resistance; they may also need to capture earlier tolerance or persistence states

References

Author note

This weekly update is intended as a structured summary of recent papers relevant to fungal diagnostics. It is designed for educational use and should be interpreted alongside local laboratory practice, specialist guidance, and the clinical context of individual patients.